Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kyntra Bio (KYNB) Equity Income (2020 - 2025)

Historic Equity Income for Kyntra Bio (KYNB) over the last 6 years, with Q3 2025 value amounting to $1.4 million.

  • Kyntra Bio's Equity Income rose 5555.56% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 1595.97%. This contributed to the annual value of $4.0 million for FY2024, which is 5384.62% up from last year.
  • Kyntra Bio's Equity Income amounted to $1.4 million in Q3 2025, which was up 5555.56% from $1.7 million recorded in Q2 2025.
  • Kyntra Bio's Equity Income's 5-year high stood at $1.7 million during Q2 2025, with a 5-year trough of -$600000.0 in Q1 2025.
  • For the 5-year period, Kyntra Bio's Equity Income averaged around $614684.2, with its median value being $565000.0 (2022).
  • Per our database at Business Quant, Kyntra Bio's Equity Income soared by 273076.92% in 2021 and then crashed by 20000.0% in 2025.
  • Over the past 5 years, Kyntra Bio's Equity Income (Quarter) stood at $343000.0 in 2021, then dropped by 18.37% to $280000.0 in 2022, then skyrocketed by 106.07% to $577000.0 in 2023, then soared by 125.3% to $1.3 million in 2024, then rose by 7.69% to $1.4 million in 2025.
  • Its Equity Income was $1.4 million in Q3 2025, compared to $1.7 million in Q2 2025 and -$600000.0 in Q1 2025.